James Yong

TL;DR: Among patients with type 1 diabetes, 12-week use of a closed-loop system, as compared with sensor-augmented pump therapy, improved glucose control, reduced hypoglycemia, and, in adults, resulted in a lower glycated hemoglobin level.

TL;DR: This analysis characterizes the impact of the technology, positive and negative aspects of living with the device, alongside participants’ expectations, hopes, and anxieties, and indicates moderately favorable impact of, and satisfaction with, both open and closed loop interventions.

TL;DR: To evaluate the experiences of families with very young children aged 1 to 7 years (inclusive) with type 1 diabetes using day‐and‐night hybrid closed‐loop insulin delivery, a large number of families opted for the day-and-night approach.

TL;DR: Unrestricted home use of day-and-night closed-loop in very young children with type 1 diabetes is feasible and safe and the use of diluted insulin during closed- loop does not provide additional benefits compared with standard strength insulin.

TL;DR: Better well-being and less hypoglycemia fear in caregivers of very young children with T1D on CamAPS FX HCL is suggested.